Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one

Home/Academy/Journal Finder/BMC Neurology

Neurology

BMC Neurology

BioMed Central (Springer Nature)

Prevention, diagnosis and management of neurological disorders, with related molecular genetics, pathophysiology and epidemiology

ISSN None (print; online only)ISSN 1471-2377 (online)Licence CC BY 4.0 or CC BY-NC-ND 4.0Access Fully open access
Fully gold open accessPublishing model
Verified 2026-11Field-level — see each tab
CiteScore4.0 2025
Impact Factor2.6 2025 · JCR (Clarivate)
QuartileQ2 2025 · Scopus CiteScore rank
Article Fee (APC)£2,390 / $3,190 / €2,690 read 13 Nov 2026 · publisher fees page
First Decision14 days (median) 2026 · publisher
Acceptance RateNot disclosed by publisher

Overview

BMC Neurology is published by BioMed Central (Springer Nature). Prevention, diagnosis and management of neurological disorders, with related molecular genetics, pathophysiology and epidemiology

Key information

PublisherBioMed Central (Springer Nature)
ISSN (Print)None / Not applicable (online-only journal; no print edition since its launch in 2001)
ISSN (Online)1471-2377
Publishing modelFully gold open access
CountryUnited Kingdom
FrequencyContinuous publication
Subject categoryNeurology (clinical); Medicine (miscellaneous)
EditorDimitra Mazaraki, PhD (Springer Nature, Berlin)
Established2001
SubmissionsNot disclosed by the publisher. Pubrica estimate: about 1,200–1,600 a year, based on about 490–580 articles published a year and a third-party acceptance-rate estimate of about 35% (not an official figure)

BMC Neurology was established in 2001 by BioMed Central (part of Springer Nature). Dimitra Mazaraki leads the journal with overall editorial responsibility, supported by an in-house team of 4 Assistant Editors and 13 Associate Editors at Springer Nature in Pune, India, per the journal’s editorial board page (November 2026).

Aims & scope

BMC Neurology considers articles on all aspects of the prevention, diagnosis and management of neurological disorders, as well as related molecular genetics, pathophysiology and epidemiology. Broad areas include:

  • Neurodegenerative diseases (e.g. Alzheimer’s, Parkinson’s, ALS)
  • Cerebrovascular disorders (e.g. stroke, aneurysms)
  • Epilepsy and seizure disorders
  • Headache and migraine
  • Neuroinflammatory and autoimmune conditions (e.g. multiple sclerosis)
  • Neuromuscular diseases (e.g. myasthenia gravis, muscular dystrophies)
  • Movement disorders
  • Cognitive and behavioural neurology
  • Infectious diseases of the nervous system
  • Genetic and molecular basis of neurological conditions
  • Clinical trials and therapeutic interventions
  • Neuroepidemiology and population-based studies
  • Diagnostic biomarkers and neuroimaging
  • Preventive strategies and public health approaches in neurology

As a BMC Series journal, BMC Neurology does not decide on the perceived interest or potential impact of a study. Manuscripts are considered if they are scientifically valid: for research articles, a clearly defined and sound research question, appropriate methodology and analysis, and adherence to community-agreed standards for the field.

Reporting guidelines accepted

CONSORT (randomised trials)STROBE (observational studies)PRISMA (systematic reviews)CARE (case reports)

Compiled by the Pubrica editorial team from the journal’s Springer Nature pages (link.springer.com/journal/12883), November 2026. Sample articles cross-checked against PubMed.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.